Xpreza 100mg Injection 1s

Introduction to Xpreza 100mg Injection 1s

Xpreza 100mg Injection 1s is a medication used primarily in the treatment of certain types of bone marrow disorders and blood cancers. It is particularly effective for conditions such as myelodysplastic syndromes, chronic myelomonocytic leukemia, and certain acute leukemias. This injection helps in managing these conditions by targeting the abnormal cells in the body.

Composition of Xpreza 100mg Injection 1s

The active ingredient in Xpreza 100mg Injection is Azacitidine. Azacitidine works by modifying the DNA in cells, which helps slow down the growth of cancer cells and restores the production of normal blood cells.

Uses of Xpreza 100mg Injection 1s

• Treatment of myelodysplastic syndromes
• Management of chronic myelomonocytic leukemia
• Therapy for certain acute leukemias

Side effects of Xpreza 100mg Injection 1s

Common side effects:

• Nausea
• Fatigue
• Low blood counts
• Reactions at the injection site
• Diarrhea

Serious side effects:

• Infections due to low immunity
• Kidney dysfunction
• Liver dysfunction

Precautions of Xpreza 100mg Injection 1s

Before starting Xpreza, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as it is not recommended during these times. Share your complete medication list with your doctor to avoid potential interactions. Avoid using Xpreza if you are allergic to Azacitidine or have advanced liver disease.

How to Take Xpreza 100mg Injection 1s

• The typical dose for adults is 75 mg per square meter of body surface area.
• It is administered as a subcutaneous or intravenous injection.
• Given daily for 7 days in a 28-day cycle.

Conclusion of Xpreza 100mg Injection 1s

Xpreza 100mg Injection 1s is a crucial medication for managing specific blood-related disorders and cancers. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always follow your healthcare provider's instructions for the best outcomes.